Today is Rare Cancers Awareness Day, a fitting day to share a story of hope. alkpositive.org.au/2026/06/25/1...

Missed our #ASCO2026 recap? 🎥 Watch the replay featuring Dr. Christine Lovly, Dr. Ken Culver, and ALK Positive leadership as they discuss the latest ALK-positive cancer research, key ASCO takeaways, and what these advances could mean for our community. youtu.be/5Di1aiUqPWU?...

We are delighted to congratulate our co-founder & chairperson, Dr Jon Graftdyk, who yesterday was awarded an Order of Australia Medal (OAM) in the King's Birthday Honours for his service to the community through cancer support groups. Bravo Jon! Well earned.

📢 Artists Chanelle Collier and Joe Wilson met in 2006 and joined their art practice in 2018. Early in 2023, Chanelle was diagnosed with a rare cancer.

ALK+ Community! Many businesses make notable donations to charities at this time of year, for tax benefits & to demonstrate corporate social responsibility. If you know a decision maker in a the corporate world please reach out & put forward our charity for their consideration. #moreresearchmorelife

Our Federal Government has a $1 billion allocation of funds for medical research annually, but only $640 million is actually being released each year. Please join us in calling on the government to release the full allocation of funds. Our lives depend on research. alkpositive.org.au/2026/05/15/h...

Congratulations to our Chairperson Jon who has been selected as a recipient of a 2026 IASLC Patient Advocate Educational Award. This educational opportunity in Seoul will undoubtedly only drive Jon further in his relentless work in patient advocacy for those with ALK Positive lung cancer.

We're back with an episode on ALK TKI sequencing in the Australian landscape. Join Prof Ben Solomon, A/Prof Tim Clay and A/Prof Malinda Itchins as they discuss treatment for this subset of NSCLC and the advances through four generations of inhibitors. Listen on Apple: buff.ly/L8TrfTn

REPOST: Webinar: 'Thriving With and Beyond Cancer' Join us on April 9, World Psycho-Oncology Day, to discover how we can support the emotional and psychological needs of patients and their families. We will be looking at fear of cancer recurrence, the burden on cancer carers, etc. www.pocog.org.au

Beautiful words from our friend and ALK Positive Australia Dep Chair Lisa Briggs in OncoDaily today. oncodaily.com/voices/lisa-...

An article that is striking a chord for many in our community. www.theguardian.com/society/2026...

The TRIANA TRI-611 human trials began last week! It is a new class of drug to treat ALK+ lung cancer, not a next gen TKI. Preclinical lab & animal studies have shown excellent results. One to watch. Go Research! trianabio.com/press-releas...

Join ALKtALK this Sunday: New Data, New Directions: Neladalkib (NVL-655) & Precision Oncology in ALK+ Cancer Featuring Alexander Drilon, MD (MSK) 🧬 Latest clinical data 🔬 How trials move toward access 🧪 Biomarker-driven insights 💬 Live Q&A 📅 March 1, 2026 🕖 7 PM ET

Can we find a way to manage drug resistance & progression in ALK+ lung cancer? Here is a link to Dr. Dane's presentation on his research into this very question. It is science-heavy, but do stick with it as the information within is truly exciting for our community. youtu.be/Z5fg4akM1eo?...

Why does resistance develop in ALK+ lung cancer, and how might it be prevented? Please join our webinar with Dr Vassiliadis, recipient of the 2026 ALK+ Inspirational Research Grant. This research goes directly to the question at the core of our community. REGISTER NOW: forms.gle/HL6MHup8UB5S...

A reminder that there is a (downloadable) Patient Information Guide on our website, which aims to provide patients & carers with clear, correct & current information about ALK positive lung cancer & its treatment in Australia. alkpositive.org.au/patient/

An incredible annoucement regarding the ALK Positive Inc Second Opinion Program & its availability to those outside the US: alkpositive.org/living-with-...

Do you have Lung Cancer and are taking a Targeted Treatment? A research project is being conducted seeking to understand the experience. It takes about 20 minutes - please consider sharing your story: mquni.au1.qualtrics.com/jfe/form/SV_... Your journey is unique. Your insights are powerful.

As Lung Cancer Awareness month comes to a close please consider buying a pair of laces & supporting much needed research into the leading cause of cancer deaths worldwide & in Australia. docs.google.com/document/d/e...

We have a Patient Information Guide that is downloadable on our website, that provides an excellent overview of ALK+ cancer & the treatments available to us in Australia. alkpositive.org.au/patient/

The '4' in Laces4Lungs represents both AJ's age - 4 months old - and the stage of his Mums ALK+ lung cancer, at diagnosis. What a powerful fundraising drive this has become. Order your laces today: docs.google.com/document/d/e...

This Lung Cancer Awareness Month, Bec & Chris Henry are pedalling 620km over 5 days, visiting every PET scan centre in WA. Their goal? To raise $10,000 for lung cancer research and treatment. Together, we can change the future of lung cancer care. Donate here >

What a week it has been for the ALK+community in Australia. Not one but TWO grants awarded this week that focus on advancing research in ALK Positive lung cancer. Go Science! thoraciconcology.org.au/inspirationa...

Identifying ALK+ resistance pathways is at the very core of what is important to us all. That makes the announcement of Dr Vassiliadis as the recipient of the ALK Positive Australia/TOGA Inspirational Grant for 2026 so thrilling. Every $ donated to ALK Positive Australia goes towards research.

An excellent presentation for those of you interested in the science behind this disease & the way we move forward with treatment. A must watch, and delivered in a very approachable way. Thanks you Ms Chen [email protected] @florianmerkle.bsky.social youtu.be/ZlYnuuvLWuE?...

November is Lung Cancer Awareness Month, a time to elevate patient voices. Please consider sharing your story. alkpositive.org.au/2025/11/05/l...

#Lungcancer can affect anyone - even if it’s the last thing you’d expect. It doesn’t care about age, history or lifestyle. Symptoms aren’t always obvious they can be subtle & not always respiratory related. Don’t ignore signs that persist. Finding it early increases your options. #LCSM

Buy your @laces4lungs today! Bling up your shoes whilst supporting ALK Positive Australia & standing with us for Lung Cancer Awareness month. Buy your Laces4Lungs today! ORDER HERE: docs.google.com/forms/d/e/1F...

ALK Positive Australia have released their inaugural newsletter! It is jam-packed with ALK+ news & achievements. If you are interested in receiving a copy please sign up here: alkpositive.org.au/membership-a...

Lung cancer is the leading cause of cancer death in Australia but receives less than 6% of the research funding. 35% of women & 15% of men diagnosed with lung cancer have never smoked. Help us drive research this November: alkpositive.org.au/donate/

ALK+ community please follow Laces4Lungs and throw your support behind this wonderful initiative, with all proceeds going to ALK+ Australia. Well done AJ - you are a star!⭐️⭐️⭐️⭐️⭐️ www.facebook.com/profile.php?...

Our website got a glow-up! Launching in the next few days — same mission, fresh new look. Got feedback or ideas? Drop us a message here or email [email protected]

"WHAT IS IT REALLY LIKE TO LIVE WITH ALK ON TKI'S IN AUSTRALIA?" Share your story in this important study. This is open to any Australian ALKie at Stage IIIB or IV on a TKI for more than 12 months. It will be an online interview for 30-60 minutes. Email [email protected] to share your story.

- 36 Australians are diagnosed with lung cancer every day. - Lung cancer is the leading cause of cancer death in Australia, but attracts less than 6% of cancer research funding. Today we acknowledge those raising awareness & working towards better outcomes for lung cancer patients.

Our Chair Jon & Dep Chair Lisa with Prof Nick Pavlakis, Prof Ben Solomon & Prof Tom John at the @togaanz.bsky.social ASM - working together for better outcomes for ALK Positive patients.

We could not be prouder of our Dep Chair & friend Lisa Briggs - the recently announced recipient of the 2025 Jeannie Ferris Award. Bravo Lisa - thank you for all that you do. You are a force!

The TOGA/ALK Positive Australia Inspirational Grant applications are now open! youtu.be/DzZBR6DPAN8?...

🤝 Eligibility: Projects must involve consumer representatives. Get ready to apply and make an impact! Let’s work together to drive real change. Find out more > buff.ly/2Tv3YUR

The ALK+ Australia & TOGA Inspirational Research Grant applications are now open! We are proudly seeking innovative research that makes a real difference for people living with ALK-positive lung cancer. thoraciconcology.org.au/inspirationa...

This recent presentation on the ALK+ vaccine & current research being undertaken in the US is truly a MUST WATCH. It brings true hope. Thank you to everyone involved, we are cheering you on from Down Under! youtu.be/GxrUsGIAFUs?...

ALK+ Community - many businesses make notable donations to charities at this time of year, for tax benefits & to demonstrate corporate social responsibility. If you know a decision maker in a the corporate world please put forward our charity for their consideration. More Research = More Life.

CALLING RESEARCHERS! The ALK Positive Australia & TOGA Inspirational Research Grant for ALK+ NSCLC is back. We are seeking innovative research that makes a real difference for people living with ALK-positive lung cancer. Now is the time to prepare a proposal. Further information coming soon.

One of our favourite days of the year. Go Research!

Promising signals from the ALEK-B ph 2 trial: combining alectinib w bevacizumab achieved 97.1% 12-mo PFS & median PFS of 39.6 months in ALK+ #NSCLC. Intracranial control also notably strong. Could this combo help overcome resistance in more aggressive ALK variants? #research #lungcancer

🎙️ Vaccines in Thoracic Oncology: The Next Frontier in Immunotherapy Join Prof Tom John, Prof Ken O'Byrne and special guest Prof Georgina Long AO as they delve into technological advances spurred by COVID-19 vaccine development, promising results from recent melanoma and lung cancer vaccine trials

Our Chairperson Jon advocating for molecular testing for all lung cancer patients on the national news, and raising awareness for ALK Positive lung cancer. youtu.be/eoAT1mDrKnM

We’re proud to have Dr. Ken Culver representing @ALK_Positive at #AACR25 in Chicago this week! We’re also partnering with @AACR on a $130K, 2-year fellowship supporting ALK+ lung cancer research 🌍 — open globally! Apply by May 15: www.aacr.org/grants/aacr-...

What if a leukemia drug could help treat ALK+ lung cancer? A new trial at @UMRogelCancerCtr is exploring gilteritinib—FDA-approved for leukemia—as a way to overcome resistance in ALK+ NSCLC. 🔗 Read the story: www.alkpositive.org/blog/2024/5/... #DrugRepurposing #ALKPositive

A must watch for anyone interested in ALK+ Lung Cancer & the advances being made in personalising treatment plans & understanding the behaviour of this cancer. A/Prof Chin talks about her incredible research project (funded by the TOGA/ALK+ Australia Inspirational grant). youtu.be/w9M-4M9fNT8